Palisade Bio, Inc.
PALI
$1.87
-$0.05-2.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 35.68% | -11.59% | -15.81% | -6.96% | -6.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.52% | -20.47% | -16.88% | -3.52% | 13.47% |
| Operating Income | -21.52% | 20.47% | 16.88% | 3.52% | -15.68% |
| Income Before Tax | -16.23% | 20.18% | 16.43% | 2.57% | -17.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.23% | 20.18% | 16.43% | 2.57% | -17.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.23% | 20.18% | 16.43% | 2.57% | -17.38% |
| EBIT | -21.52% | 20.47% | 16.88% | 3.52% | -15.68% |
| EBITDA | -21.52% | 20.47% | 16.88% | 3.52% | -15.69% |
| EPS Basic | 87.51% | 80.22% | 75.54% | 69.01% | 58.28% |
| Normalized Basic EPS | 87.51% | 79.73% | 75.04% | 68.50% | 57.69% |
| EPS Diluted | 87.51% | 80.22% | 75.54% | 69.01% | 58.28% |
| Normalized Diluted EPS | 87.51% | 79.73% | 75.04% | 68.50% | 57.69% |
| Average Basic Shares Outstanding | 3,834.89% | 367.28% | 327.01% | 320.49% | 210.37% |
| Average Diluted Shares Outstanding | 3,834.89% | 367.28% | 327.01% | 320.49% | 210.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |